tiprankstipranks
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market
Holding DE:6Y4?
Track your performance easily

Vicore Pharma Holding AB (6Y4) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

6Y4 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Vicore
Pharma Holding AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6Y4 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:6Y4 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

6Y4 Financial Forecast

6Y4 Earnings Forecast

Next quarter’s earnings estimate for 6Y4 is -€0.03 with a range of -€0.03 to -€0.03. The previous quarter’s EPS was -€0.05. 6Y4 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 53.85% of the time in the same period. In the last calendar year 6Y4 has Underperformed its overall industry.
Next quarter’s earnings estimate for 6Y4 is -€0.03 with a range of -€0.03 to -€0.03. The previous quarter’s EPS was -€0.05. 6Y4 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 53.85% of the time in the same period. In the last calendar year 6Y4 has Underperformed its overall industry.

6Y4 Sales Forecast

Next quarter’s sales forecast for 6Y4 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 6Y4 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.69% of the time in the same period. In the last calendar year 6Y4 has Underperformed its overall industry.
Next quarter’s sales forecast for 6Y4 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 6Y4 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.69% of the time in the same period. In the last calendar year 6Y4 has Underperformed its overall industry.

6Y4 Analyst Recommendation Trends

Rating
Mar 23
May 23
Strong Buy
1
2
Buy
0
0
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
1
2
In the current month, 6Y4 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6Y4 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

6Y4 Stock Forecast FAQ

What is DE:6Y4’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:6Y4’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:6Y4, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Vicore Pharma Holding AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Vicore Pharma Holding AB’s share price target?
      Currently, no data Available
      What do analysts say about Vicore Pharma Holding AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Vicore Pharma Holding AB?
      To buy shares of DE:6Y4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis